Skip to main content

UBS Group AG

Position in DRMA — Dermata Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in DRMA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$21,666
-$21,419 QoQ
Shares Held
18,600
-49.6% QoQ
Ownership
0.462%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 13 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DRMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. DRMA ranks #423 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DRMA

Export CSV
34 filing rows on record
Report Date Value (USD) Shares
2026-06-30 DRMAW 1,804
2026-06-30 $21,666 16,796
2026-03-31 DRMAW 1,304
2026-03-31 $43,085 35,608
2025-12-31 $2,869 1,237
2025-09-30 DRMAW 1,279
2025-09-30 $50,435 10,047
2025-06-30 DRMAW 1,880
2025-06-30 $53,208 90,955
2025-03-31 DRMAW 2,617
2025-03-31 $75,913 70,290
2024-12-31 DRMAW 4,142
2024-12-31 $18,729 13,874
2024-09-30 DRMAW 4,242
2024-09-30 $2,455 1,497
2024-06-30 DRMAW 5,042
2024-06-30 $4,074 1,705
2024-03-31 DRMAW 1,485
2023-12-31 DRMAW 3,353
2023-09-30 DRMAW 5,610
2023-09-30 $138 131
2023-06-30 $11,566 7,010
2023-03-31 DRMAW 1,800
2023-03-31 $4,444 3,445
2022-12-31 DRMAW 6,905
2022-12-31 $15,258 37,308
2022-09-30 DRMAW 9,100
2022-09-30 $7,694 14,798
2022-06-30 $7,284 11,207
2022-03-31 DRMAW 3,267
2022-03-31 $5,403 4,323
2021-12-31 DRMAW 6,960
2021-09-30 DRMAW 3,000
2021-09-30 $848 189